Biology of Blood and Marrow Transplantation
Volume 16, Issue 7 , Pages 985-993 , July 2010

Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: Role of the Conditioning Regimen and the Type of Transplantation

  • Marta Palomo

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • Corresponding Author InformationCorrespondence and reprint requests: Marta Palomo, Pre-doctoral Hemotherapy-Hemostasis Department, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain.
    • ,
  • Maribel Diaz-Ricart

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Carla Carbo

      Affiliations

    • Immune Disease Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts
    • ,
  • Montserrat Rovira

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Francesc Fernandez-Aviles

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Carmen Martine

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Gabriela Ghita

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Ginés Escolar

      Affiliations

    • Hemotherapy-Hemostasis Department, Centre de Diagnòstic Biomèdic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
    • ,
  • Enric Carreras

      Affiliations

    • Stem Cell Transplantation Unit, Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

Received 8 October 2009 ,Accepted 4 February 2010.

References 

  1. Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb Haemost. 2005;3:1392–1406
  2. Aird WC. The endothelium: a primer. UpToDate 17. 1. Available at: www.uptodate.com, 2009.
  3. Mohler ER. Endothelial dysfunction. UpToDate 17. 1. Available at: www.uptodate.com, 2009.
  4. Palomo M, Diaz-Ricart M, Carbo C, et al. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. Biol Blood Marrow Transplant. 2009;15:537–546
  5. DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol. 2003;284:G1045–G1052
  6. DeLeve LD, Wang X, Kanel GC, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology. 2003;38:900–908
  7. Nurnberger W, Willers R, Burdach S, Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol. 1997;74:221–224
  8. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004;44:294–304
  9. George JN. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep. 2005;4:167–169
  10. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:893–898
  11. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med. 2002;166:641–645
  12. Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359:2078–2083
  13. Biedermann BC. Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21:129–138
  14. Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Hiller E. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant. 1997;19:909–914
  15. Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood. 2004;103:3603–3605
  16. Serradell M, Diaz-Ricart M, Cases A, et al. Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica. 2002;87:1053–1061
  17. Serradell M, Diaz-Ricart M, Zurbano MJ, et al. Uremic media affects hemostatic properties of human endothelial cells in culture and increases the production of von Willebrand factor. Nefrologia. 2002;22:33–41
  18. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–259
  19. Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778–783
  20. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129:93–100
  21. Kremer Hovinga JA, Mottini M, Lammle B. Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods. J Thromb Haemost. 2006;4:1146–1148
  22. Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood. 1995;86:4184–4193
  23. Eissner G, Multhoff G, Gerbitz A, et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood. 2002;100:334–340
  24. Tiemann C, Prohaska W, Körfer R, Körner M, Brinkmann T, Kleesiek K. Effect of cyclosporine A on the release of tissue factor pathway inhibitor from endothelial cells in heart transplant patients and cell culture. Eur J Clin Chem Clin. 1997;35:661–667
  25. Woywodt A, Schroeder M, Mengel M, et al. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension. 2003;41:720–723
  26. Fuste B, Mazzara R, Escolar G, Merino A, Ordinas A, Diaz-Ricart M. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica. 2004;89:578–585
  27. Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci USA. 1998;95:14423–14428
  28. Vermeulen M, Le PF, Gagnerault MC, Mary JY, Sainteny F, Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood. 1998;92:894–900
  29. Peyvandi F, Siboni SM, Lambertenghi DD, et al. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. Br J Haematol. 2006;134:187–195
  30. Matsuda Y, Hara J, Osugi Y, et al. Serum levels of soluble adhesion moluecules in stem cell transplantation-related complications. Bone Marrow Transplant. 2001;27:977–982
  31. Mannucci PM, Capoferri C, Canciani MT. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol. 2004;126:213–218
  32. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584–589
  33. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068–2101
  34. Elangbam CS, Qualls CW, Dahlgren RR. Cell adhesion molecules-update. Vet Pathol. 1997;34:61–73
  35. Andersen J, Heilmann C, Jacobsen N, Bendtzen K, Muller K. Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation. Int Immunopharmacol. 2005;5:67–71
  36. Gustot T, Lemmers A, Louis E, et al. Profile of soluble cytokine receptors in Crohn's disease. Gut. 2005;54:488–495
  37. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 1992;89:4845–4849

 Financial disclosure: See Acknowledgments on page 992.

PII: S1083-8791(10)00064-9

doi: 10.1016/j.bbmt.2010.02.008

Biology of Blood and Marrow Transplantation
Volume 16, Issue 7 , Pages 985-993 , July 2010

Article Tools

* Image Usage & Resolution